The NF1 Gene Neurofibromatosis Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the NF1 gene, which are responsible for Neurofibromatosis Type 1 (NF1). NF1 is a genetic disorder characterized by the development of multiple noncancerous (benign) tumors of nerves and skin (neurofibromas) and areas of abnormal skin color (café-au-lait spots). The condition varies greatly among individuals in its severity, symptoms, and the age at which symptoms begin.
This genetic test involves analyzing the patient's DNA to detect mutations in the NF1 gene, which is crucial for diagnosing NF1 accurately and for understanding the risk of transmitting the condition to offspring. Early diagnosis through genetic testing can lead to better management and treatment of the symptoms associated with NF1, potentially improving the quality of life for those affected.
The cost of the NF1 Gene Neurofibromatosis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art laboratory setting by a team of experienced geneticists and laboratory technicians, ensuring high accuracy and reliability of the results. Upon completion, a comprehensive report is provided, which can be an invaluable resource for affected individuals, their families, and their healthcare providers in making informed decisions regarding management and care.
The "SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the SPRED1 gene, which are known to cause Legius syndrome, a condition closely resembling Neurofibromatosis Type 1 (NF1). Legius syndrome, also known as Neurofibromatosis Type 1-like syndrome, shares many clinical features with NF1, including café-au-lait spots and freckling, but lacks the neurofibromas that are characteristic of NF1. The test is crucial for distinguishing between these two conditions, allowing for accurate diagnosis and appropriate management.
This genetic test involves analyzing the patient's DNA to detect any mutations in the SPRED1 gene that are indicative of Legius syndrome. Early diagnosis through this genetic testing is essential for the implementation of suitable monitoring and intervention strategies, potentially improving the patient's quality of life and reducing the risk of complications associated with misdiagnosis.
The test is available at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The cost of the SPRED1 Gene Neurofibromatosis Type 1-Like Syndrome Genetic Test is 4400 AED. Given the complexity and the specialized nature of this genetic test, the price reflects the intricate processes involved in ensuring accurate and reliable results. Individuals who exhibit symptoms suggestive of NF1 or Legius syndrome or have a family history of these conditions may consider undergoing this test after consulting with a healthcare professional to confirm the diagnosis and receive personalized medical advice.
The NF2 Gene Neurofibromatosis Type 2 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the NF2 gene, which is associated with Neurofibromatosis Type 2 (NF2). This condition is characterized by the growth of noncancerous tumors in the nervous system, most commonly affecting the brain and spinal cord. The test is crucial for individuals who have symptoms of NF2, have a family history of the condition, or are at risk of passing it on to their offspring.
Performed at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect any alterations in the NF2 gene that may lead to the development of the disorder. The process requires a blood sample from the patient, which is then subjected to comprehensive genetic analysis using advanced laboratory techniques.
The cost of the NF2 Gene Neurofibromatosis Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic testing process, and the provision of a detailed report explaining the results. The outcome of the test can provide essential information for the diagnosis, treatment planning, and management of Neurofibromatosis Type 2, helping patients and their families make informed decisions about their health care.
The GFI1 gene neutropenia nonimmune chronic idiopathic of adults genetic test is a specialized diagnostic tool designed to identify mutations in the GFI1 gene, which are associated with a rare form of neutropenia. Neutropenia is a condition characterized by abnormally low levels of neutrophils, a type of white blood cell essential for fighting off infections. Unlike other forms of neutropenia, the nonimmune chronic idiopathic type in adults does not result from autoimmune responses or external factors but is believed to have a genetic basis, hence the focus on the GFI1 gene.
DNA Labs UAE offers this specific genetic test to individuals who exhibit symptoms of neutropenia without a clear cause, aiming to provide a definitive diagnosis through the detection of genetic abnormalities in the GFI1 gene. The test is crucial for affected individuals as it can guide the development of a tailored treatment plan and inform them about the potential genetic implications for their family members.
The cost of the GFI1 gene neutropenia nonimmune chronic idiopathic of adults genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the specialized nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the GFI1 gene. While the cost may seem significant, the value of obtaining a precise diagnosis and the potential for improved disease management and treatment outcomes can be invaluable for those affected by this rare condition.
The GFI1 Gene Nevere Congenital Neutropenia Type 2 Autosomal Dominant Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test, costing 4400 AED, is designed to identify mutations in the GFI1 gene, which are implicated in the development of Severe Congenital Neutropenia Type 2 (SCN2), an autosomal dominant disorder. SCN2 is characterized by a marked decrease in neutrophil counts, leading to an increased susceptibility to infections from a very young age. The GFI1 gene plays a crucial role in the development and function of neutrophils, and mutations in this gene can disrupt these processes, resulting in the clinical manifestations of SCN2. The test involves the collection of a DNA sample, typically through a blood draw, which is then analyzed for the presence of specific mutations in the GFI1 gene. Identifying these mutations can aid in the diagnosis of SCN2, allowing for the implementation of appropriate treatment and management strategies for affected individuals. DNA Labs UAE offers this genetic testing service as part of their comprehensive suite of diagnostic tools aimed at enhancing patient care through precise genetic insights.
The G6PC3 gene plays a crucial role in the proper functioning of neutrophils, which are essential components of the immune system responsible for fighting infections. Mutations in the G6PC3 gene can lead to a condition known as Severe Congenital Neutropenia Type 4, an autosomal recessive disorder. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition. The disorder is characterized by a marked decrease in the number of neutrophils, making individuals highly susceptible to frequent and severe infections.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the G6PC3 gene, providing a crucial diagnostic tool for families suspected of carrying this condition. The test is particularly important for early diagnosis and management of the disorder, helping to guide treatment decisions and preventive measures against infections. The cost of the G6PC3 gene neutropenia severe congenital type 4 autosomal recessive genetic test is 4400 AED.
By opting for this test, individuals and families can gain valuable insights into their genetic makeup, enabling informed healthcare decisions and the possibility of genetic counseling. It's a critical step towards managing and mitigating the impacts of this rare but serious condition.
The VPS45 Gene Neutropenia Severe Congenital Type 5 Autosomal Recessive Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. This test is designed to identify mutations in the VPS45 gene, which are associated with Severe Congenital Neutropenia Type 5 (SCN5). SCN5 is a rare autosomal recessive disorder characterized by a severe decrease in neutrophil count, leading to increased susceptibility to infections from an early age. The condition can present significant clinical challenges, including life-threatening infections if not diagnosed and managed appropriately.
The test involves analyzing the patient's DNA to detect mutations in the VPS45 gene, providing crucial information for accurate diagnosis and guiding treatment strategies. It is particularly important for families with a history of SCN5 or for patients presenting symptoms suggestive of neutropenia. The cost of the test is 4400 AED, reflecting the comprehensive nature of the genetic analysis and the expertise required to interpret the results.
By opting for this test at DNA Labs UAE, patients and healthcare providers can expect a high level of accuracy and reliability, backed by the lab's reputation for excellence in genetic diagnostics. Early and precise diagnosis through this test can significantly impact the management and prognosis of patients with Severe Congenital Neutropenia Type 5, paving the way for tailored treatments and improved quality of life.
The JAGN1 gene neutropenia severe congenital type 6 autosomal recessive genetic test is a specialized diagnostic assessment offered by DNA Labs UAE. This test is designed to identify mutations in the JAGN1 gene, which are linked to a rare condition known as severe congenital neutropenia type 6. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Severe congenital neutropenia is characterized by a marked decrease in neutrophils, a type of white blood cell crucial for fighting off infections. Individuals with this condition are more susceptible to frequent and severe infections from a very young age. Identifying mutations in the JAGN1 gene can confirm a diagnosis of severe congenital neutropenia type 6, inform treatment decisions, and help with family planning.
The test at DNA Labs UAE is priced at 4400 AED. It involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the JAGN1 gene. The results can provide valuable information for affected individuals and their families regarding the nature of the condition, potential treatment approaches, and the risk of passing the condition on to future generations. DNA Labs UAE offers this test with professional guidance and support, ensuring that patients and their families understand the implications of the test results.
The RAC2 Gene Neutrophil Immunodeficiency Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the RAC2 gene. These mutations are known to cause a rare form of immunodeficiency that specifically affects neutrophils, a type of white blood cell crucial for fighting infections. Individuals with mutations in the RAC2 gene may have increased susceptibility to infections, demonstrating the importance of this test for early diagnosis and management.
The test involves collecting a DNA sample, usually through a blood draw, which is then analyzed in the laboratory for any genetic alterations in the RAC2 gene. The results can provide valuable information for clinicians to develop an appropriate treatment and management plan for affected individuals.
The cost of the RAC2 Gene Neutrophil Immunodeficiency Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This cost covers the full process of genetic analysis, from sample collection to the provision of a detailed report. Given the complexity and the specialized nature of this test, the price reflects the extensive resources required for accurate diagnosis and the expertise of the laboratory personnel involved.
For families and individuals facing symptoms or a family history suggestive of neutrophil immunodeficiency syndrome, this test offers a critical pathway to understanding their condition and tailoring their healthcare accordingly.
The WNT10A gene odonto-onycho-dermal dysplasia genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the WNT10A gene that are known to cause odonto-onycho-dermal dysplasia (OODD). OODD is a rare genetic disorder characterized by abnormalities in the development of teeth, nails, and skin. This comprehensive test plays a crucial role in the early diagnosis and management of the condition, enabling targeted interventions and genetic counseling for affected individuals and their families.
DNA Labs UAE, a leading facility in genetic testing, conducts this test with precision and accuracy, ensuring reliable results. The test is priced at 4400 AED, reflecting the advanced technology and expertise involved in the analysis. By identifying the specific mutations in the WNT10A gene, healthcare professionals can better understand the disorder's manifestation in each patient, paving the way for personalized treatment plans and improving the quality of life for those affected by OODD.
